Management of Resistant Hypertension: Do Not Give Up on Medication.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.Journal of clinical hypertension (Greenwich, Conn.) · 2018
   Trial
2. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.Journal of hypertension · 2016
   Trial
3. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.Hypertension (Dallas, Tex. : 1979) · 2021
   Review
4. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.Pharmacological research · 2017
   Review
5. Controlling Hypertension: We Have the Tools-We Just Need to Use Them.Journal of general internal medicine · 2017
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.